Association between decreased pulmonary endothelial cell thrombomodulin and local fibrin deposition in pneumonia

C M Albertson1, K K Richter, B J Kudryk

  • 1Department of Surgery, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205, USA.

Insights

Bronchopneumonia significantly reduces thrombomodulin (TM) in lung tissue, leading to fibrin deposition and potential hypercoagulability. This study links decreased TM to increased clotting in pneumonia patients.

Area of Science:

  • Pulmonary Medicine
  • Hematology
  • Immunopathology

Background:

  • Thrombomodulin (TM) is crucial for anticoagulation via thrombin-activated protein C.
  • Inflammatory mediators can inactivate and downregulate TM.
  • Bronchopneumonia involves inflammation that may affect TM levels and coagulation.

Purpose of the Study:

  • To investigate changes in TM immunoreactivity in bronchopneumonia.
  • To determine if reduced TM correlates with fibrin deposition (hypercoagulability) in the lungs.

Main Methods:

  • Immunohistochemistry using double antibody staining for TM and fibrin on lung tissue.
  • Assessment of inflammatory markers (interleukin-1alpha, tumor necrosis factor-alpha, myeloperoxidase).
  • Comparison between pneumonia patients and trauma controls.

Main Results:

  • Markedly decreased endothelial TM staining in alveolar walls and small vessels in bronchopneumonia areas.
  • Significant fibrin immunoreactivity observed in areas with reduced TM.
  • Variable TM levels and less fibrin deposition in areas with mild inflammation.

Conclusions:

  • Bronchopneumonia is associated with decreased TM immunoreactivity in lung vasculature.
  • Reduced TM levels correlate with local fibrin deposition, suggesting hypercoagulability.
  • Findings highlight TM's role in pulmonary pathophysiology during pneumonia.

Related Concept Videos

Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...